Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10842)
All Articles published online
|
Publishing Process of This Article
|
Feb 6, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Okamoto M, Kobayashi M, Yonemitsu Y, Koido S, Homma S. Dendritic cell-based vaccine for pancreatic cancer in Japan. World J Gastrointest Pharmacol Ther 2016; 7(1): 133-138 [PMID: 26855819 DOI: 10.4292/wjgpt.v7.i1.133] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v7/i1/133.htm |
| Number | Citing Articles |
| 1 |
João Calmeiro, Mylene Carrascal, Célia Gomes, Amílcar Falcão, Maria Teresa Cruz, Bruno Miguel Neves. Dendritic Cells. 2018; doi: 10.5772/intechopen.78804
|
| 2 |
Jia-qiao Fan, Meng-Fei Wang, Hai-Long Chen, Dong Shang, Jugal K. Das, Jianxun Song. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01151-3
|
| 3 |
Ping Li, Linan Jia, Xiaobo Bian, Shutao Tan. Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities. Current Treatment Options in Oncology 2023; 24(12): 1703 doi: 10.1007/s11864-023-01143-7
|
| 4 |
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. European Journal of Pharmacology 2024; 969: 176451 doi: 10.1016/j.ejphar.2024.176451
|
| 5 |
Tao Sun, Bo Sun, Yanyan Cao, Jiayun Liu, Juan Chen, Bin Liang, Chuansheng Zheng, Xuefeng Kan. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2023; 166: 115351 doi: 10.1016/j.biopha.2023.115351
|
| 6 |
Sitti Rahma Abdul Hafid, Ammu Kutty Radhakrishnan. Palm Tocotrienol-Adjuvanted Dendritic Cells Decrease Expression of the SATB1 Gene in Murine Breast Cancer Cells and Tissues. Vaccines 2019; 7(4): 198 doi: 10.3390/vaccines7040198
|
| 7 |
João Calmeiro, Mylène A. Carrascal, Adriana Ramos Tavares, Daniel Alexandre Ferreira, Célia Gomes, Amílcar Falcão, Maria Teresa Cruz, Bruno Miguel Neves. Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells. Pharmaceutics 2020; 12(2): 158 doi: 10.3390/pharmaceutics12020158
|
| 8 |
Yu-Hsuan Hung, Li-Tzong Chen, Wen-Chun Hung. The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy. Biomedicines 2022; 10(4): 926 doi: 10.3390/biomedicines10040926
|
| 9 |
Hisashi Nagai, Ryusuke Karube. WT1 Dendritic Cell Vaccine Therapy Improves Immune Profile and Prolongs Progression-Free Survival in End-Stage Lung Cancer. Cureus 2023; doi: 10.7759/cureus.47320
|
| 10 |
João Calmeiro, Mylène Carrascal, Célia Gomes, Amílcar Falcão, Maria Teresa Cruz, Bruno Miguel Neves. Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0716-8
|
| 11 |
Sebastian Lundgren, Emelie Karnevi, Jacob Elebro, Björn Nodin, Mikael C. I. Karlsson, Jakob Eberhard, Karin Leandersson, Karin Jirström. The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype. Journal of Translational Medicine 2017; 15(1) doi: 10.1186/s12967-017-1256-y
|
| 12 |
Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola Annels, Adam E. Frampton. Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(17): 4265 doi: 10.3390/cancers15174265
|
| 13 |
Miquel Lozano, Joan Cid, Daniel Benitez-Ribas, Manel Juan Otero. Technical Challenges in the Manufacture of Dendritic Cell Cancer Therapies. European Oncology & Haematology 2019; 15(1): 22 doi: 10.17925/EOH.2019.15.1.22
|
| 14 |
Jennifer D. Elster, Deepa K. Krishnadas, Kenneth G. Lucas. Dendritic cell vaccines: A review of recent developments and their potential pediatric application. Human Vaccines & Immunotherapeutics 2016; 12(9): 2232 doi: 10.1080/21645515.2016.1179844
|
| 15 |
Ryouichi Tsunedomi, Yoshitaro Shindo, Masao Nakajima, Kiyoshi Yoshimura, Hiroaki Nagano. The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers. Expert Review of Molecular Diagnostics 2023; 23(12): 1121 doi: 10.1080/14737159.2023.2281482
|
| 16 |
Otto Phanstiel. An overview of polyamine metabolism in pancreatic ductal adenocarcinoma. International Journal of Cancer 2018; 142(10): 1968 doi: 10.1002/ijc.31155
|
| 17 |
Josefa A. Rodríguez. HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation. Oncology Letters 2017; 14(4): 4415 doi: 10.3892/ol.2017.6784
|
| 18 |
Xin Zhang, Zheng Xu, Xiangpeng Dai, Xiaoling Zhang, Xueju Wang. Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1104860
|
| 19 |
Anton Deicher, Roland Andersson, Bobby Tingstedt, Gert Lindell, Monika Bauden, Daniel Ansari. Targeting dendritic cells in pancreatic ductal adenocarcinoma. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0585-0
|
| 20 |
Shigeo Koido, Masato Okamoto, Shigetaka Shimodaira, Haruo Sugiyama. Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer. Immunotherapy 2016; 8(11): 1309 doi: 10.2217/imt-2016-0031
|
| 21 |
Subhamay Adhikary, Surajit Pathak, Vignesh Palani, Ahmet Acar, Antara Banerjee, Nader I. Al-Dewik, Musthafa Mohamed Essa, Sawsan G. A. A. Mohammed, M. Walid Qoronfleh. Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach. Biomedicines 2024; 12(1): 217 doi: 10.3390/biomedicines12010217
|